'The Global Self Monitoring Blood Glucose (SMBG) Devices Market will be Worth $27.42bn by 2022' Says Visiongain Report

'The Global Self Monitoring Blood Glucose (SMBG) Devices Market will be Worth $27.42bn by 2022' Says Visiongain Report PR Newswire LONDON, November 13, 2012 LONDON, November 13, 2012 /PRNewswire/ -- A new report by Visiongain, a London-based business information provider, predicts that the global market for diabetes monitoring devices will be worth $27.42bn by 2022. The market generated sales of $9.7bn in 2011. Medical devices are playing an increasingly important role in diabetes. Products such as blood glucose monitors and insulin pumps have now become the cornerstone for the management of blood glucose levels. More invasive devices are being increasingly used in diabetes, such as those used in bariatric surgery. While such products continue to dominate the diabetes care devices market, there is a growing interest in a new innovative technology, known as continuous glucose monitoring, which can offer regular blood glucose measurements (typically every few minutes). This is particularly useful as it provides a greater insight into glucose levels throughout the day through the implantation of a small sensor under the skin. It is hoped that in the future these implantable sensors may be able to automatically adjust insulin infusion rates delivered by insulin pumps.